Patient safety is a top priority at Rush Foundation Hospital, which was the first hospital in East Mississippi and West Alabama to deploy Xenex LightStrike™ Germ-Zapping Robots™ to enhance environmental cleanliness by disinfecting and destroying hard-to-kill germs, bacteria and superbugs in hard-to-clean places.
ResCare, one of the nation’s largest home and community-based health services providers to complex populations, announced it has a new name.
BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products.
Embolx, Inc., a medical device company developing microcatheters for arterial embolization procedures, today announced CE Certifications for its next-generation family of Sniper® Balloon Occlusion Microcatheters for the treatment of cancerous tumors, enlarged prostate and uterine fibroids.
Oska Wellness, a technology company committed to developing consumer health and wellness products, announced today that the company will donate $10.00 for each Oska Pulse sold to the National Fibromyalgia & Chronic Pain Association during "Pain Awareness Month," September 1 – 30.
TARIS, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, today announced positive preliminary safety and efficacy data from its clinical study of TAR-302 for the treatment of patients with idiopathic overactive bladder (OAB) refractory to oral therapy.
A free and informative new guide, How to Pick a Partner to Manage Your Intensivist Services, offers the 20 must-ask questions hospitals should pose to every candidate—along with the ideal answers—to determine the most qualified partner to manage their intensivist services.
Late-breaking data published and presented today confirm that the non-invasive HeartFlow® FFRct Analysis enables physicians to effectively differentiate patients in need of coronary stenting or bypass surgery from those who can be managed with medications alone.
Atrium Health's President and CEO, Gene Woods, has been honored as one of 2018's 100 Most Influential People in Healthcare by Modern Healthcare, being named in the top 25 of the most significant innovators, trailblazers and thought-leaders across the healthcare field.
MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska.